Show Search Form
human indexable | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||||
registered interest | |||||||||||||||||
answer date | |||||||||||||||||
date | |||||||||||||||||
date tabled | |||||||||||||||||
ddp created | |||||||||||||||||
answering body |
|
||||||||||||||||
question status | Tabled | ||||||||||||||||
answering dept id | 208 | ||||||||||||||||
answering dept short name | Foreign, Commonwealth and Development Office | ||||||||||||||||
answering dept sort name | Foreign, Commonwealth and Development Office | ||||||||||||||||
ddp modified |
|
||||||||||||||||
hansard heading | Developing Countries: Genito-urinary Medicine | ||||||||||||||||
house id | 2 | ||||||||||||||||
identifier | HL2253 | ||||||||||||||||
legislature |
|
||||||||||||||||
parliament number | 58 | ||||||||||||||||
question first answered |
|
||||||||||||||||
question text | To ask His Majesty's Government what steps they are taking to achieve universal access to sexual and reproductive health and rights as per Sustainable Development Goal target 5.6. | ||||||||||||||||
session |
|
||||||||||||||||
session number | 4 | ||||||||||||||||
tabling member printed |
|
||||||||||||||||
title | House of Lords Tabled Parliamentary Question 2023/24 HL2253 | ||||||||||||||||
type |
|
||||||||||||||||
uin | HL2253 | ||||||||||||||||
version | 1 | ||||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||||
answer |
|
||||||||||||||||
creator |
|
||||||||||||||||
publisher |
|
||||||||||||||||
tabling member |
|
human indexable | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
published | |||||||||||||||||
registered interest | |||||||||||||||||
answer date | |||||||||||||||||
date | |||||||||||||||||
date tabled | |||||||||||||||||
ddp created | |||||||||||||||||
answering body |
|
||||||||||||||||
question status | Tabled | ||||||||||||||||
answering dept id | 17 | ||||||||||||||||
answering dept short name | Health and Social Care | ||||||||||||||||
answering dept sort name | Health and Social Care | ||||||||||||||||
ddp modified |
|
||||||||||||||||
hansard heading | Contraceptives: Taxation | ||||||||||||||||
house id | 2 | ||||||||||||||||
identifier | HL1963 | ||||||||||||||||
legislature |
|
||||||||||||||||
parliament number | 58 | ||||||||||||||||
question first answered |
|
||||||||||||||||
question text | To ask His Majesty's Government, further to their policy paper 2024 voluntary scheme for branded medicines pricing, access and growth: summary of the heads of agreement, published on 20 November 2023, what assessment they have made of any potential detrimental impact on women's health if the tax on the contraceptive implant Nexplanon is increased to 35 per cent. | ||||||||||||||||
session |
|
||||||||||||||||
session number | 4 | ||||||||||||||||
tabling member printed |
|
||||||||||||||||
title | House of Lords Tabled Parliamentary Question 2023/24 HL1963 | ||||||||||||||||
type |
|
||||||||||||||||
uin | HL1963 | ||||||||||||||||
version | 1 | ||||||||||||||||
written parliamentary question type | Ordinary | ||||||||||||||||
answer |
|
||||||||||||||||
creator |
|
||||||||||||||||
publisher |
|
||||||||||||||||
tabling member |
|